Drug & medication recalls Moderate risk

PHENYLephrine HCl 400 mcg/ in 0 recalled over sterility concerns

Recall date
November 9, 2023
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
SCA Pharmaceuticals, LLC recalls PHENYLephrine HCl 400 mcg/10 mL in 0.9% Sodium Chloride Injection, (Concentration = 40 mcg/mL), 10 mL fill 12 mL Syring…
Recall number
D-0418-2024
FDA classification
Class II
Brand / firm
SCA Pharmaceuticals, LLC
Sold / distributed
Nationwide in the USA

Why it was recalled

Lack of Assurance of Sterility

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

PHENYLephrine HCl 400 mcg/10 mL in 0.9% Sodium Chloride Injection, (Concentration = 40 mcg/mL), 10 mL fill 12 mL Syringe, Rx Only, SCA Pharmaceuticals, 755 Rainbow Rd. Windsor, CT 06095, NDC 70004-0811-12, Bar Code 70004081112.

Get recall alerts

Free email alert whenever SCA Pharmaceuticals, LLC has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: SCA Pharmaceuticals, LLC